Crohn's Disease is a chronic inflammatory condition of the gastrointestinal tract, primarily affecting the small and large intestine. It is a type of Inflammatory Bowel Disease (IBD) and is characterized by abdominal pain, diarrhea, fatigue, weight loss, and malnutrition. Symptoms can range from mild to severe and can be managed with medications, lifestyle changes, and in some cases, surgery. The Crohn's Disease market within the context of Gastroenterology is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global market for Crohn's Disease treatments will reach $7.5 billion by 2027. The market is driven by the increasing prevalence of the disease, the development of new treatments, and the growing awareness of the condition. Companies in the Crohn's Disease market include AbbVie, Pfizer, Janssen, Takeda, and Celgene. These companies are involved in the development and marketing of treatments for Crohn's Disease, including biologics, small molecules, and other therapies. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
